Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2602 | 2123 | 42.8 | 87% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
370 | 16580 | NITRIC OXIDE//PEROXYNITRITE//NITRIC OXIDE-BIOLOGY AND CHEMISTRY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MOL INNOVAT DRUG DISCOVERY | Address | 13 | 26% | 2% | 42 |
2 | N HYDROXYGUANIDINES | Author keyword | 12 | 86% | 0% | 6 |
3 | LERNER FDN | Address | 9 | 83% | 0% | 5 |
4 | HEME REDUCTION | Author keyword | 8 | 70% | 0% | 7 |
5 | SELECTIVE NEURONAL NITRIC OXIDE SYNTHASE INHIBITORS | Author keyword | 8 | 100% | 0% | 5 |
6 | CARDIOVASC MEDDAVIS HEART LUNG | Address | 6 | 80% | 0% | 4 |
7 | IMMUNOL NB3 | Address | 6 | 100% | 0% | 4 |
8 | N OMEGA HYDROXY L ARGININE | Author keyword | 5 | 60% | 0% | 6 |
9 | LOW FREQUENCY EPR IN VIVO PHYSIOL | Address | 5 | 63% | 0% | 5 |
10 | MED MED MED HEMATOL ONCOL | Address | 5 | 63% | 0% | 5 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | OXYGENASE DOMAIN | 212 | 92% | 4% | 83 |
2 | SUBUNIT DIMERIZATION | 107 | 93% | 2% | 40 |
3 | OXYGENASE DIMER | 92 | 92% | 2% | 36 |
4 | HYDROXY L ARGININE | 89 | 47% | 7% | 142 |
5 | MACROPHAGE NO SYNTHASE | 87 | 88% | 2% | 42 |
6 | REDUCTASE DOMAIN | 71 | 74% | 2% | 53 |
7 | TETRAHYDROBIOPTERIN BINDING | 65 | 95% | 1% | 21 |
8 | PTERIN | 65 | 60% | 3% | 70 |
9 | 2 DOMAIN CONSTRUCT | 60 | 100% | 1% | 20 |
10 | BIDOMAIN STRUCTURE | 57 | 95% | 1% | 19 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Nitric oxide synthases: structure, function and inhibition | 2001 | 2008 | 210 | 56% |
Mammalian nitric oxide synthases | 1999 | 549 | 124 | 76% |
Nitric oxide and macrophage function | 1997 | 2385 | 170 | 31% |
Structure-function studies on nitric oxide synthases | 2005 | 153 | 113 | 83% |
NO synthase: Structures and mechanisms | 2010 | 89 | 125 | 74% |
Nitric oxide synthases: regulation and function | 2012 | 305 | 166 | 16% |
Tetrahydrobiopterin in nitric oxide synthase | 2013 | 13 | 53 | 92% |
Update on mechanism and catalytic regulation in the NO synthases | 2004 | 259 | 45 | 62% |
NITRIC OXIDES SYNTHASES - PROPERTIES AND CATALYTIC MECHANISM | 1995 | 919 | 131 | 61% |
Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain | 2014 | 8 | 234 | 61% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOL INNOVAT DRUG DISCOVERY | 13 | 26% | 2.0% | 42 |
2 | LERNER FDN | 9 | 83% | 0.2% | 5 |
3 | CARDIOVASC MEDDAVIS HEART LUNG | 6 | 80% | 0.2% | 4 |
4 | IMMUNOL NB3 | 6 | 100% | 0.2% | 4 |
5 | LOW FREQUENCY EPR IN VIVO PHYSIOL | 5 | 63% | 0.2% | 5 |
6 | MED MED MED HEMATOL ONCOL | 5 | 63% | 0.2% | 5 |
7 | TECHNOPORT | 4 | 75% | 0.1% | 3 |
8 | CHEM LIFE PROC | 4 | 10% | 1.8% | 38 |
9 | LSOD | 3 | 100% | 0.1% | 3 |
10 | DRUG DISCOVERY CHEM BIOL | 3 | 19% | 0.8% | 16 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000165792 | VASCULAR ENDOTHELIAL DYSFUNCTION//MOL CARDIOBIOL PROGRAM//VASCULAR ENDOTHELIUM DYSFUNCTION |
2 | 0.0000156958 | TYPE I INTERLEUKIN 1 RECEPTOR//INOS PROMOTER//ORG SCI TECHNOL |
3 | 0.0000132461 | ARTIF ORGANS TRANSPLANTAT GENE THER Y//CHEM TECH INC//CHRONIC RENAL TRANSPLANT FAILURE |
4 | 0.0000131796 | AMINOETHYL ISOTHIOUREA//VASCULAR HYPOREACTIVITY//N G METHYL L ARGININE HYDROCHLORIDE |
5 | 0.0000121278 | ZENTRUM PHARMAKOL//URINARY NITRITE NITRATE//AIDS PATHOGENESIS MOL THER EUT |
6 | 0.0000113079 | COLLAGENOUS PROTEIN BIOSYNTHESIS//NOS3//IMMUNOL IMMUNOTHER IE CANC |
7 | 0.0000101064 | NADPH DIAPHORASE//7 NITROINDAZOLE//NEURONAL NITRIC OXIDE SYNTHASE |
8 | 0.0000100593 | GRP IMMUNOBIOL//HUMAN NUTR METAB DIS LIM 25//EXPT ONCOL LIM 24 |
9 | 0.0000093527 | AGR REPROD PHYSIOL//CATTEDRA A//IST FISIOL VET |
10 | 0.0000076438 | NITRIC OXIDE SYNTHASE I//NOS I//CENT ULTRASTRUCT TEAM |